The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain

A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man

Bennett, G. J., & Xie, Y.-K. (1988) · Pain · doi:10.1016/0304-3959(88)90209-6 · Cited by 5,376

A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia

Hargreaves, K., Dubner, R. A., Brown, F. J., Flores, C., & Joris, J. L. (1988) · Pain · doi:10.1016/0304-3959(88)90026-7 · Cited by 5,155

Extra-territorial pain in rats with a peripheral mononeuropathy: mechano-hyperalgesia and mechano-allodynia in the territory of an uninjured nerve

Tal, M., & Bennett, G. J. (1994) · Pain · doi:10.1016/0304-3959(94)90013-2 · Cited by 436

Biochemical and pharmacological characterisatioN OF SR141716A, the first potent and selective brain cannabinoid receptor antagonist

Rinaldi, M. L., Barth, F., Héaulme, M., Alonso, R., Shire, D. J., Congy, C., Soubrié, P., Brelière, J.-C., & Fur, G. L. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00174-5 · Cited by 307

Conformationally restrained analogs of pravadoline: nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptor

D'Ambra, T. E., Estep, K. G., Bell, M. R., Eissenstat, M. A., Josef, K. A., Ward, S. J., Haycock, D. A., Baizman, E. R., & Casiano, F. M. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00079a016 · Cited by 296

Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy

Mao, J., Price, D. D., Hayes, R. L., Lü, J., Mayer, D. J., & Frenk, H. (1993) · Brain Research · doi:10.1016/0006-8993(93)91368-3 · Cited by 238

Dextrorphan relieves neuropathic heat-evoked hyperalgesia in the rat

Tal, M., & Bennett, G. J. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90058-s · Cited by 144

Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine.

Welch, S. P., Thomas, C., & Patrick, G. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24328-2 · Cited by 124

Behavioral manifestations of an experimental model for peripheral neuropathy produced by spinal nerve ligation in the primate

Carlton, S. M., Lekan, H. A., Kim, S. H., & Chung, J. M. (1994) · Pain · doi:10.1016/0304-3959(94)90090-6 · Cited by 121

Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2

Hohmann, A. G., Martin, W. J., Tsou, K., & Walker, J. M. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00196-d · Cited by 120

Pre-emptive antinociceptive effects of a synthetic cannabinoid in a model of neuropathic pain

Guindon, J., Desroches, J., Dani, M., & Beaulieu, P. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.04.060 · Cited by 24

Selective modulation of the cannabinoid type 1 (CB 1 ) receptor as an emerging platform for the treatment of neuropathic pain

Banister, S. D., Kumar, K. K., Kumar, V., Kobilka, B. K., & Malhotra, S. V. (2019) · MedChemComm · doi:10.1039/c8md00595h · Cited by 22

Novel targets for Spinal Cord Injury related neuropathic pain

Ahmed, M. M., King, K. C., Pearce, S. M., Ramsey, M. A., Miranpuri, G. S., & Resnick, D. K. (2011) · Annals of Neurosciences · doi:10.5214/ans.0972.7531.1118413 · Cited by 23

Evaluation of protective effects of non-selective cannabinoid receptor agonist WIN 55,212-2 against the nitroglycerine-induced acute and chronic animal models of migraine: A mechanistic study

Mohammadi-Vosough, E., Rahimi, V. B., Masoud, S. A., Mirkarimi, H. R., Demneh, M. K., Abed, A., Banafshe, H. R., & Askari, V. R. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116670 · Cited by 20

The endocannabinoid and endovanilloid systems and their interactions in neuropathic pain

Maione, S., Starowicz, K., Palazzo, E., Rossi, F., & Marzo, V. D. (2006) · Drug Development Research · doi:10.1002/ddr.20098 · Cited by 21

Preclinical science regarding cannabinoids as analgesics: An overview

Lynch, M. (2005) · Pain Research and Management · doi:10.1155/2005/169093 · Cited by 20

Cannabinoids for Acute Pain Management: Approaches and Rationale

Botea, M. O., Andereggen, L., Urman, R. D., Luedi, M. M., & Romero, C. S. (2024) · Current Pain and Headache Reports · doi:10.1007/s11916-024-01252-4 · Cited by 20

Characterization of Cancer-Induced Nociception in a Murine Model of Breast Carcinoma

de Almeida, A. S., Rigo, F. K., Prá, S. D.-T. D., Milioli, A. M., Dalenogare, D. P., Pereira, G. C., Ritter, C. D. S., Peres, D. S., Antoniazzi, C. T. D. D., Stein, C. D. S., et al. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00666-8 · Cited by 20

The Synthetic Cannabinoid R(+)WIN55,212-2 Augments Interferon-β Expression via Peroxisome Proliferator-activated Receptor-α

Downer, E. J., Clifford, E., Amu, S., Fallon, P. G., & Moynagh, P. N. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.371757 · Cited by 21

Central glucocorticoid receptors modulate the expression of spinal cannabinoid receptors induced by chronic morphine exposure

Lim, G., Wang, S., & Mao, J. (2005) · Brain Research · doi:10.1016/j.brainres.2005.08.002 · Cited by 20

Tetrahydrocannabinol and Cannabidiol for Pain Treatment—An Update on the Evidence

Safi, K., Sobieraj, J., Błaszkiewicz, M., Żyła, J., Salata, B., & Dzierżanowski, T. (2024) · Biomedicines · doi:10.3390/biomedicines12020307 · Cited by 21

Synthesis of α‐N‐Heteroaryl Ketones by Nickel‐Catalyzed Chemo‐, Regio‐ and Enantioselective Carbonylation of Alkenes and N ‐Alkenyl Heteroarenes

Chen, X., Yu, Q., & Shu, W. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202423426 · Cited by 18

Cannabinoid receptor CB1-immunoreactive nerve fibres in painful and non-painful human tooth pulp

Beneng, K., Renton, T. F., Yilmaz, Z., Yiangou, Y., & Anand, P. (2010) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2010.04.005 · Cited by 18

Antinociceptive Synergy Between the Cannabinoid Receptor Agonist WIN 55,212-2 and Bupivacaine in the Rat Formalin Test

Kang, S., Kim, C. H., Lee, H., Kim, D. Y., Han, J. I., Chung, R. K., & Lee, G. Y. (2007) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000255291.38637.26 · Cited by 18

Antihyperalgesic effect of the cannabinoid agonist WIN55,212-2 is mediated through an interaction with spinal metabotropic glutamate-5 receptors in rats

Hama, A. T., & Urban, M. O. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2003.12.111 · Cited by 18

Continuous infusion of the cannabinoid WIN 55,212–2 to the site of a peripheral nerve injury reduces mechanical and cold hypersensitivity

Lever, I. J., Pheby, T., & Rice, A. S. C. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707210 · Cited by 17

Lipid inhibitors of high affinity glycine transporters: Identification of a novel class of analgesics

Carland, J. E., Handford, C. A., Ryan, R. M., & Vandenberg, R. J. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.08.012 · Cited by 17

Clinical implications for cannabinoid use in the rheumatic diseases: Potential for help or harm?

Fitzcharles, M., McDougall, J. J., Ste‐Marie, P. A., & Padjen, I. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34522 · Cited by 16

Druggable Targets in Endocannabinoid Signaling

Gregus, A. M., & Buczynski, M. W. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-50621-6_8 · Cited by 16

Pharmacologie des dérivés cannabinoïdes : applications au traitement de la douleur ?

Beaulieu, P., & Rice, A. S. C. (2002) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/s0750-7658(02)00663-9 · Cited by 16

Cannabinoid receptor 1 ligands: Biased signaling mechanisms driving functionally selective drug discovery

Tian, L., Qiang, T., Liu, S., Zhang, B., Zhang, Y., Zhang, B., Hu, J., Zhang, J., Qi, L., Ke, C., et al. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108795 · Cited by 14

Pharmacological and behavioral characterization of the saphenous chronic constriction injury model of neuropathic pain in rats

Gündüz, Ö., Oltulu, Ç., Guven, R., Buldum, D., & Ulugöl, A. (2011) · Neurological Sciences · doi:10.1007/s10072-011-0761-7 · Cited by 13

Metabotropic Glutamate and Cannabinoid Receptor Crosstalk in Periaqueductal Grey Pain Processing

Palazzo, E., de Novellis, V., Marabese, I., Rossi, F., & Maione, S. (2006) · Current Neuropharmacology · doi:10.2174/157015906778019545 · Cited by 12

Design, synthesis and evaluation of novel angiotensin II receptor 1 antagonists with antihypertensive activities

Bao, X., Zhu, W., Shan, T.-L., Wu, Z. K., Zhang, R., Liao, P., Mei-zhen, Z., Tang, H., Yan, Y., & Chen, Z. (2017) · RSC Advances · doi:10.1039/c7ra03915h · Cited by 12

Identification of the role of endogenous cannabinoids in pain modulation: strategies and pitfalls

Walker, J. M., Huang, S. M., Strangman, N. M., & Sañudo-Peña, M. C. (2000) · Journal of Pain · doi:10.1016/s1526-5900(00)90085-3 · Cited by 12

Cannabis Medicine 2.0: Nanotechnology-Based Delivery Systems for Synthetic and Chemically Modified Cannabinoids for Enhanced Therapeutic Performance

Żółnowska, I., Gostyńska, A., Jelińska, A., & Stawny, M. (2025) · Nanomaterials · doi:10.3390/nano15161260 · Cited by 14

Cannabis sativa L. Extract Alleviates Neuropathic Pain and Modulates CB1 and CB2 Receptor Expression in Rat

Bartkowiak-Wieczorek, J., Bienert, A., Czora-Poczwardowska, K., Kujawski, R., Szulc, M., Mikołajczak, P. Ł., Wizner, A.-M., Jamka, M., Hołysz, M., Wielgus, K., et al. (2024) · Biomolecules · doi:10.3390/biom14091065 · Cited by 12

Therapeutic Targeting of Peripheral Cannabinoid Receptors in Inflammatory and Neuropathic Pain States

Spigelman, I. (2009) · Frontiers in neuroscience · doi:10.1201/9781439812105-c5 · Cited by 12

Tetrahydrocannabinol zur Therapie chronischer Schmerzen

Elsner, F., Radbruch, L., & Sabatowski, R. (2001) · Der Schmerz · doi:10.1007/s004820170024 · Cited by 11

The Therapeutic Potential of Drugs that Target Cannabinoid Receptors or Modulate the Tissue Levels or Actions of Endocannabinoids

Pertwee, R. G. (2008) · Springer eBooks · doi:10.1007/978-0-387-76678-2_38 · Cited by 11

Medical marijuana.

Marmor, J. B. (1998) · Europe PMC (PubMed Central) · Cited by 10

Prescribing Cannabinoids for Multiple Sclerosis

Pertwee, R. G. (1999) · CNS Drugs · doi:10.2165/00023210-199911050-00001 · Cited by 10

Current Nonopioid Small Molecule Approaches Toward the Treatment of Neuropathic Pain

Cioffi, C. L., Lotsaris, I., Chater, R. C., Pati, T. K., Suleria, K., Mahesh, G., Singh, S., Peiser-Oliver, J., Mohammadi, S. A., & Vandenberg, R. J. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01126 · Cited by 9

The effect of spinally administered WIN 55,212-2, a cannabinoid agonist, on thermal pain sensitivity in diabetic rats.

Jahanabadi, S., Hadian, M. R., Shamsaee, J., Tavangar, S. M., Abdollahi, A., Dehpour, A. R., & Mehr, S. E. (2016) · Europe PMC (PubMed Central) · Cited by 9

Cannabinoid receptor agonists from Conus venoms alleviate pain-related behavior in rats

Jergová, S., Perez, C., Imperial, J. S., Gajavelli, S., Jain, A., Abin, A., Olivera, B. M., & Sagen, J. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173182 · Cited by 9

Effects of WIN55,212-2 on voltage-gated sodium channels in trigeminal ganglion neurons of rats

Fu, H., Xiao, J. M., Cao, X., Ming, Z. Y., & Liu, L. J. (2008) · Neurological Research · doi:10.1179/016164107x228642 · Cited by 9

Cannabinoids and Pain Control in the Periphery

McDougall, J. J. (2009) · Wiley eBooks · doi:10.1002/9780470522226.ch13 · Cited by 9

Cannabinoids For the Treatment of Neuropathic Pain: Are They Safe and Effective?

Gutierrez, T., & Hohmann, A. G. (2011) · Future Neurology · doi:10.2217/fnl.11.6 · Cited by 8

The role of endocannabinoids in visceral hyposensitivity induced by rapid eye movement sleep deprivation in rats: Regional differences

Hou, X. (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2010.547 · Cited by 8

Cancer pain syndromes

Twycross, R., & Bennett, M. (2008) · CRC Press eBooks · doi:10.1201/b13440-3 · Cited by 8

Cannabinoide—Signaltransduktion und Wirkung

Rukwied, R., Gauter, B., Schley, M. T., & Konrad, C. J. (2004) · Der Schmerz · doi:10.1007/s00482-004-0349-8 · Cited by 8

The Use of Cannabinoids in the Treatment of Peripheral Neuropathy and Neuropathic Pain: A Systematic Review

Choi, J., Li, G., Stephens, K. L., Timko, M. P., & DeGeorge, B. R. (2024) · The Journal Of Hand Surgery · doi:10.1016/j.jhsa.2024.09.015 · Cited by 7

Disability-specific genes GRIN1, GRIN2 and CNR1 show injury-dependent protein expression in the lumbar spinal cord of CCI rats

Bembrick, A. L., Boorman, D. C., & Keay, K. A. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.134982 · Cited by 7

Anti-Nociceptive and Anti-Aversive Drugs Differentially Modulate Distinct Inputs to the Rat Lateral Parabrachial Nucleus

Teuchmann, H. L., Hogri, R., Heinke, B., & Sandkühler, J. (2022) · Journal of Pain · doi:10.1016/j.jpain.2022.03.234 · Cited by 7

Utilisation du dronabinol dans le traitement des douleurs neuropathiques réfractaires : retour d’expérience des patients suivis dans un Centre d’évaluation et de traitement de la douleur

Richet, E., Ferret, L., Gaboriau, L., Charpentier, P., Dujardin, L., Fulcrand, J., & Boursier, A. (2022) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2022.12.005 · Cited by 7

Medical Management of Traumatic Neuropathies

Gregg, J. M. (2001) · Oral and Maxillofacial Surgery Clinics of North America · doi:10.1016/s1042-3699(20)30149-7 · Cited by 7

Cannabinoids and pain relief

Holdcroft, A., & Patel, P. (2001) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.1.1.92 · Cited by 7

Cannabinoid Receptors and Their Ligands in Brain and Other Tissues

Pertwee, R. G. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-710-9_18 · Cited by 7

Pharmacological Evaluation of Cannabinoid Receptor Modulators Using GRABeCB2.0 Sensor

Shivshankar, S., Nimely, J., Puhl, H. L., & Iyer, M. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25095012 · Cited by 6

Effect of Postoperative Analgesic Exposure to the Cannabinoid Receptor Agonist WIN55 on Osteogenic Differentiation and Spinal Fusion in Rats

Yun, C., Haleem, M. S., Jeong, S., Oyer, M. A., Driscoll, J. A., Chang, K. Y., Yun, J., Paul, J. T., Lubbe, R., Stock, S. R., et al. (2021) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.20.00573 · Cited by 6

The Role of Endocannabinoid System in Neuroprotection: Molecular Targets and Therapeutic Opportunities

Thapa, S., & Singh, S. K. (2023) · Integrative Medicine Reports · doi:10.1089/imr.2022.0091 · Cited by 4

Modulation of Pain by Endocannabinoids in the Periphery

Uhelski, M. L., Khasabova, I. A., & Simone, D. A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.79673 · Cited by 5

Acute Pressure Block of the Sciatic Nerve Relieves Clinical Pain But Not Cold Pressor Pain

He, J., Jiang, X., Zhao, B., Xu, S., Zhang, F., Wei, P., & Chen, Q. (2010) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e3181c8fc68 · Cited by 5

Opioid System Involvement in Cannabinoid Tolerance and Dependence

Maldonado, R. J. (1882) · Humana Press eBooks · doi:10.1007/978-1-59259-343-9_12 · Cited by 5

Participation of the cannabinoid system and the NO/cGMP/KATP pathway in serotonin-induced peripheral antinociception

Aguiar, D. D., Petrocchi, J. A., da Silva, G. C., Lemos, V. S., Castor, M. G. M. E., Perez, A. C., Duarte, I. D. G., & Romero, T. R. L. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137536 · Cited by 4

Cannabis for pain management: Pariah or panacea?

Hudson, R., & Puvanenthirarajah, N. (2018) · University of Western Ontario Medical Journal · doi:10.5206/uwomj.v87i1.1922 · Cited by 4

The cannabinoid receptor agonists, anandamide and WIN 55,212-2, do not directly affect mu opioid receptors expressed in Xenopus oocytes

Kracke, G. R., Stoneking, S. P., Ball, J. M., Tilghman, B. M., Washington, C. C., Hotaling, K. A., Johnson, J. O., & Tobias, J. D. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0201-7 · Cited by 4

Chronic neuropathic pain: Pathomechanism and pharmacology

Urbán, L., Nagy, I., & Bevan, S. (2001) · Drug Development Research · doi:10.1002/ddr.10015 · Cited by 4

Recent data on cannabinoids and their pharmacological implications in neuropathic pain.

Coman, O. A., Păunescu, H., Coman, L., Bădărău, A., & Fulga, I. (2008) · PubMed Central · Cited by 3

The endocannabinoid anandamide inhibits kinin B1 receptor sensitization through cannabinoid CB1 receptor stimulation in human umbilical vein

Pelorosso, F. G., Gago, J. E., del Rey, G., Menéndez, S. D., Errasti, A. E., & Rothlin, R. P. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.10.058 · Cited by 3

Commentary on “Cannabinoids modulate pain by multiple mechanisms of action”

Ward, S. J. (2000) · Journal of Pain · doi:10.1016/s1526-5900(00)90083-x · Cited by 3

Levels of bioactive endogenous lipids and health-related quality of life in Chronic Idiopathic Axonal Polyneuropathy

Lind, J., Stensson, N., Gerdle, B. U. C., & Ghafouri, N. (2022) · Upsala Journal of Medical Sciences · doi:10.48101/ujms.v127.8577 · Cited by 2

Pharmacological plasticity associated with neuropathic pain states

Chapman, V., & Dickenson, A. H. (2002) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8129-6_5 · Cited by 2

Therapeutic Potentials and uses of Cannabinoid Agonists in Health and Disease Conditions

Ibegbu, A. O., Mullaney, I., Fyfe, L., & MacBean, D. (2012) · Murdoch University Research Portal · Cited by 2

Beyond opioids: cannabis and the changing landscape of cancer pain

Khoshjabinzadeh, A., McGinnis, R., Afolabi, Y., & Keniston, L. (2025) · Academia oncology. · doi:10.20935/acadonco7974 · Cited by 1

Involvement of Serotonergic System in Cannabinoid Analgesia

Dogrul, A. B., Seyrek, M., Yalçın, B., & Ulugöl, A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7940-6_13 · Cited by 1

The Management of Neuropathic Pain

Toth, C., & Moulin, D. E. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139152211.019 · Cited by 1

Pharmacotherapy of chronic orofacial pain

Benoliel, R., & Sharav, Y. (2008) · Elsevier eBooks · doi:10.1016/b978-0-7234-3412-2.10016-1 · Cited by 1

Emerging therapeutic strategies for chronic pain

Abrahams, M., & Munglani, R. (2000) · Emerging Drugs · doi:10.1517/14728214.5.4.385 · Cited by 1

Clinical and Experimental Reports of Marihuana and Cannabinoids in Spastic Disorders

Consroe, P. F. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-710-9_60 · Cited by 1

Cannabinoid targets for pain therapeutics

Huang, S. M., & Walker, J. M. (2005) · Birkhäuser-Verlag eBooks · doi:10.1007/3-7643-7358-x_8 · Cited by 1

Evaluation critique des modèles expérimentaux de «douleur chronique» chez l’animal

Bouhassira, D. (2001) · Douleur et Analgésie · doi:10.1007/bf03007508 · Cited by 1

Local Neuroimmune Interactions in Visceral Hyperalgesia Bradykinin, Neurotrophins, and Cannabinoids

Rice, A. S. C. (2003) · CRC Press eBooks · doi:10.1201/9780203911259-12 · Cited by 1

Persistent inflammation promotes endocannabinoid release and presynaptic cannabinoid 1 receptor desensitizationPreprint

Bouchet, C. A., Janowsky, A. J., & Ingram, S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.20.496891 · Cited by 1

Exploring the molecular basis to the regulatory effects of Cannabinoids on toll-like receptor signalling

Clifford, E. (2010) · Maynooth University ePrints and eTheses Archive (Maynooth University)

Pharmacological and Nonpharmacological Treatment of Neuropathic Pain

Sommer, C. (2001) · Pain and headache/Research and clinical studies in headache · doi:10.1159/000061880

Marijuana: Pharmacology and Interaction with the Endocannabinoid System

Wiley, J. L., & Martin, B. R. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn040

Toxicology of Substances of Abuse

Vo, E., & Crisce, D. D. (2012) · doi:10.1002/9781118340851.ch10

Molecular Mediators of Pain

Chaudhary, P., & Burchiel, K. J. (2005) · KARGER eBooks · doi:10.1159/000084468

Study of the interaction between 3,4 methylenedioximethamphetamine and the endocannabinoid system

Touriño, C. (2009) · Repositori digital de la UPF (Universitat Pompeu Fabra)

Methods and Applications of Analgesic Assays

Zhao, M. (2009) · doi:10.1002/9780470522202.ch13

Rational for the Use of Opioids in Nociceptive Transmission

Freye, E. C. K., & Levy, J. V. (2008) · Springer eBooks · doi:10.1007/978-1-4020-5947-6_1

Cannabis and the U.S. Controlled Substances Act

Gettman, J. (2001) · Journal of Cannabis Therapeutics · doi:10.1300/j175v01n01_09

The Treatment of Neuropathic Pain with Cannabinoid Based Nanotechnology

Linsell, O. (2013) · Otago University Research Archive (University of Otago)

Ultra-Low Dose Antagonist Effects on Cannabinoids and Opioids in Models of Pain: Is Less More?

Paquette, J. J. (2007)

Cannabinoid modulation of nociception and nociceptor activity during inflammation.

Potenzieri, C. (2009) · University of Minnesota Digital Conservancy (University of Minnesota)

Changes in endocannabinoid signaling contribute to the anti-hyperalgesic effect of URB597 in a murine model of persistent inflammation.

Lindberg, A. E. (2011) · University of Minnesota Digital Conservancy (University of Minnesota)

Cannabinoids

Ware, M. A. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139152211.022

Vanilloïdes, cannabinoïdes et nociception: aspects anatomiques

Conrath, M., Fischer, J., Salio, C., Franzoni, M. F., & Doly, S. (2001) · Douleur et Analgésie · doi:10.1007/bf03012690

Functional Activity and Switching of Novel Cannabinergic Ligands

Koertge, B. (2015) · doi:10.21007/etd.cghs.2015.0164

Activation of cannabinoid CB1 and CB2 receptors suppresses painful peripheral neuropathy evoked by the chemotherapeutic agent vincristine

Rahn, E. J. (2006)

Identificação e ações do receptor vanilóide de potencial transitório 1 (TRPV-1) na superfície ocular e glândula lacrimal

Dias, L. C. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2017.tde-19072016-171535

Characterization of new antinociceptive ligands in rat model: preclinical studies

Kovács, G. (2017) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.4155

Optimization and Development of In Vitro Bioassays to Determine Structure-Activity Relationships for Cannabinoid Receptor 1 and Cannabinoid Receptor 2

Husni, A. S. (2012)

Opioid and Non-opioid Therapy

Maher, D. P., Shah, B. J., & Vorobeychik, Y. (2019) · Springer eBooks · doi:10.1007/978-3-030-27447-4_19 · Cited by 1

Applied physiology: neuropathic pain

Wallace, V. C. J., & Rice, A. S. C. (2008) · CRC Press eBooks · doi:10.1201/b13472-1

Canabinoides

Rice, A. S. C. (2007) · Elsevier eBooks · doi:10.1016/b978-84-8174-949-6.50034-4

Effets comportementaux des cannabinoïdes Données animales

Thiébot, M.-H., & Chaperon, F. (2001) · Douleur et Analgésie · doi:10.1007/bf03012691

Cannabinoids

Pertwee, R. G. (2003) · CRC Press eBooks · doi:10.1201/9780203911259.ch56

Cannabinoids

Rice, A. S. C. (2006) · Elsevier eBooks · doi:10.1016/b0-443-07287-6/50039-4

Repeated treatment with the synthetic cannabinoid WIN 55,212-2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain

Costa, B., Colleoni, M., Conti, S., Trovato, A. E., Bianchi, M., Sotgiu, M. L., & Giagnoni, G. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705587 · Cited by 89

Effects of a cannabinoid agonist on spinal nociceptive neurons in a rodent model of neuropathic pain

Liu, C., & Walker, J. M. (2006) · Journal of Neurophysiology · doi:10.1152/jn.00498.2006 · Cited by 37

The synthetic cannabinoid WIN55,212‐2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain

Bridges, D., Ahmad, K., & Rice, A. S. C. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704110 · Cited by 222

Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain

Ahmed, M. M., Rajpal, S., Sweeney, C., Gerovac, T. A., Allcock, B., McChesney, S. L., Patel, A. U., Tilghman, J. I., Miranpuri, G. S., & Resnick, D. K. (2010) · The Spine Journal · doi:10.1016/j.spinee.2010.08.015 · Cited by 26

Role of Cannabinoid Receptors in Crocin-Induced Hypoalgesia in Neuropathic Pain in Rats

Vafaei, A. A., Safakhah, H. A., Jafari, S., Tavasoli, A., Rashidy‐Pour, A., Ghanbari, A., Seyedinia, S. A., & Tarahomi, P. (2020) · Journal of Experimental Pharmacology · doi:10.2147/jep.s250738 · Cited by 14